Author
Listed:
- Mariona Graupera
(Centre for Cell Signalling, Institute of Cancer, Queen Mary, University of London, Charterhouse Square, London EC1M 6BQ, UK)
- Julie Guillermet-Guibert
(Centre for Cell Signalling, Institute of Cancer, Queen Mary, University of London, Charterhouse Square, London EC1M 6BQ, UK)
- Lazaros C. Foukas
(Centre for Cell Signalling, Institute of Cancer, Queen Mary, University of London, Charterhouse Square, London EC1M 6BQ, UK)
- Li-Kun Phng
(Vascular Biology Laboratory, Cancer Research UK London Research Institute, 44 Lincoln’s Inn Fields, London WC2A 3PX, UK)
- Robert J. Cain
(King’s College London, New Hunt’s House, Guy’s Campus)
- Ashreena Salpekar
(Centre for Cell Signalling, Institute of Cancer, Queen Mary, University of London, Charterhouse Square, London EC1M 6BQ, UK)
- Wayne Pearce
(Centre for Cell Signalling, Institute of Cancer, Queen Mary, University of London, Charterhouse Square, London EC1M 6BQ, UK)
- Stephen Meek
(Gene Targeting Laboratory, The Institute for Stem Cell Research, University of Edinburgh, West Mains Road, Edinburgh EH9 3JQ, UK)
- Jaime Millan
(King’s College London, New Hunt’s House, Guy’s Campus)
- Pedro R. Cutillas
(Centre for Cell Signalling, Institute of Cancer, Queen Mary, University of London, Charterhouse Square, London EC1M 6BQ, UK)
- Andrew J. H. Smith
(Gene Targeting Laboratory, The Institute for Stem Cell Research, University of Edinburgh, West Mains Road, Edinburgh EH9 3JQ, UK)
- Anne J. Ridley
(King’s College London, New Hunt’s House, Guy’s Campus)
- Christiana Ruhrberg
(Institute of Ophthalmology, University College London)
- Holger Gerhardt
(Vascular Biology Laboratory, Cancer Research UK London Research Institute, 44 Lincoln’s Inn Fields, London WC2A 3PX, UK)
- Bart Vanhaesebroeck
(Centre for Cell Signalling, Institute of Cancer, Queen Mary, University of London, Charterhouse Square, London EC1M 6BQ, UK)
Abstract
Phosphoinositide 3-kinase: Role of the p110a isoform The p110α isoform of phosphoinositide 3-kinase is shown to play a critical role in normal and pathological angiogenesis. In particular, it is needed to mediate the migration of endothelial cells downstream of VEGF receptor activation, acting upstream of RhoA. This finding suggests that p110a-selective inhibitors, in addition to their direct effects in inhibiting cancer cell proliferation, will also impact on pathological angiogenesis in tumours.
Suggested Citation
Mariona Graupera & Julie Guillermet-Guibert & Lazaros C. Foukas & Li-Kun Phng & Robert J. Cain & Ashreena Salpekar & Wayne Pearce & Stephen Meek & Jaime Millan & Pedro R. Cutillas & Andrew J. H. Smith, 2008.
"Angiogenesis selectively requires the p110α isoform of PI3K to control endothelial cell migration,"
Nature, Nature, vol. 453(7195), pages 662-666, May.
Handle:
RePEc:nat:nature:v:453:y:2008:i:7195:d:10.1038_nature06892
DOI: 10.1038/nature06892
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:453:y:2008:i:7195:d:10.1038_nature06892. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.